During the past decade, Tacoma/Valley Radiation Oncology Centers-Gig Harbor conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 21 clinical trials were completed, i.e. on average, 56.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 18 clinical trials were completed. i.e. 900% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tacoma/Valley Radiation Oncology Centers-Gig Harbor" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "NRG Oncology" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tacoma/Valley Radiation Oncology Centers-Gig Harbor" #1 collaborator was "National Cancer Institute (NCI)" with 29 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Tacoma/Valley Radiation Oncology Centers-Gig Harbor" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Cervical Adenocarcinoma" (3 trials), "Chronic Lymphocytic Leukemia" (3 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Tacoma/Valley Radiation Oncology Centers-Gig Harbor" in a lesser frequency.

Most popular intervention types in "Tacoma/Valley Radiation Oncology Centers-Gig Harbor" are "Drug" (40 trials), "Other" (39 trials), "Biological" (18 trials), "Procedure" (11 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Quality-of-Life Assessment" (12 trials), "Computed Tomography" (7 trials), "Nivolumab" (7 trials) and "Cisplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Tacoma/Valley Radiation Oncology Centers-Gig Harbor" are 37 trials for "All" genders and 13 trials for "Female" genders.

Currently, there are NaN active trials in "Tacoma/Valley Radiation Oncology Centers-Gig Harbor". undefined are not yet recruiting, 5 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Tacoma/Valley Radiation Oncology Centers-Gig Harbor, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Tacoma/Valley Radiation Oncology Centers-Gig Harbor, 0 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".